All-cause and disease-related health care costs associated with recurrent venous thromboembolism

Thrombosis and Haemostasis

Volumn 110, Issue 6, 2013, Pages 1288-1297

  Lefebvre, Patrick ^a   Laliberté, François ^a   Nutescu, Edith A ^b   Duh, Mei Sheng ^c   LaMori, Joyce ^d   Bookhart, Brahim K ^d   Olson, William H ^d   Dea, Katherine ^a   Hossou, Yvonnick ^a   Schein, Jeff ^d   Kaatz, Scott ^e  

^a GROUPE D ANALYSE   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c ANALYSIS GROUP   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^e HURLEY MEDICAL CENTER   (United States)

Author keywords

Complications; Costs; Recurrent venous thromboembolism; Risks

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DERMATITIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTOPENIA; ULCER; VEIN INSUFFICIENCY; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

COMPLICATIONS; COSTS; RECURRENT VENOUS THROMBOEMBOLISM; RISKS;

ADULT; AGED; COHORT STUDIES; HEALTH CARE COSTS; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 84888415179     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-05-0425     Document Type: Article

References (39)

1. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.
2. The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657-662.
3. Hansson PO, Sorbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 2000; 160: 769-774.
4. Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160: 761-768.
5. MMWR Morb Mortal Wkly Rep. Venous thromboembolism in adult hospitalizations-United States, 2007-2009 Centers for Disease Control and Prevention (CDC) 2012; 61: 401-404.
6. Heit JA, Cohen AT, Anderson FA Jr, et al. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the U. S. Blood 2005; 106: 267a. Poster presented at: 47th Annual Meeting of the American Society of Hematology (ASH); December 10-14, 2005; Atlanta, GA.
7. The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Office of the Surgeon General (US); National Heart, Lung, and Blood Institute (US). Rockville (MD): Office of the Surgeon General (US); 2008.
8. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82: 203-205.
9. Kopcke D, Harryman O, Benbow EW, et al. Mortality from pulmonary embolism is decreasing in hospital patients. J R Soc Med 2011; 104: 327-331.
10. Heit JA. The Epidemiology of Venous Thromboembolism in the Community: Implications for Prevention and Management. J Thromb Thrombolysis 2006; 21: 23-29.
11. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107: I22-30.
12. Labropoulos N, Spentzouris G, Sobreira ML. Clinical Significance of Recurrent Venous Thromboembolism. J Vasc Bras 2010; 9: 72-75.
13. Adcock DM. Recurrence of Thromboembolism: Determining Risk. Clin Hemost Rev 2005; 19: 1-5.
14. Brandjes DP, Büller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-762.
15. Kahn SR, Solymoss S, Lamping DL, et al. Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. J Gen Intern Med 2000; 15: 425-429.
16. Ginsberg JS, Turkstra F, Buller HR, et al. Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study. Arch Intern Med 2000; 160: 669-672.
17. Fanikos J, Piazza G, Zayaruzny M, et al. Long-Term Complications of Medical Patients with Hospital-Acquired Venous Thromboembolism. Thromb Haemost 2009; 102: 688-693.
18. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
19. Mahan CE, Borrego ME, Woersching AL, et al. Venous thromboembolism: Annualised United States Models for Total, Hospital-Acquired and Preventable Costs Utilising Long-Term Attack Rates. Thromb Haemost 2012; 108: 291-302.
20. MacDougall DA, Feliu AL, Boccuzzi SJ, et al. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Am J Health-Syst Pharm 2006; 63: S5-S15.
21. Kirson NY, Birnbaum HG, Ivanova JI, et al. Excess Costs Associated with Patients with Chronic Thrombolic Pulmonary Hypertension in a US Privately Insured Population. Appl Health Econ Health Policy 2011; 9: 377-387.
22. Bagelman SM, Hursting MJ, Aghababian RV, et al. Heparin-induced thrombocytopenia from venous thromboembolism treatment. J Intern Med 2005; 258: 563-572.
23. Kitchens CS. Thrombocytopenia due to acute venous thromboembolism and its role in expanding the differential diagnosis of heparin-induced thrombocytopenia. Am J Hematol 2004; 76: 69-73.
24. Coon WW, Willis PW 3rd, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh Community Health Study. Circulation 1973; 48: 839-846.
25. Decousus H, Quéré I, Presles E, et al. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med 2010; 152: 218-224.
26. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008; 28: 370-372.
27. White JV, Ryjewski C. Chronic venous insufficiency. Perspect Vasc Surg Endovasc Ther 2005; 17: 319-327.
28. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.
29. Vedantham S. Deep venous thrombosis: the opportunity at hand. Am J Roentgenol 2009; 193: 922-927.
30. Wolinsky CD, Waldrof H. Chronic venous disease. Med Clin North Am 2009; 93: 1333-1346.
31. Yamaki T, Nozaki M. Patterns of venous insufficiency after an acute deep vein thrombosis. J Am Coll Surg 2005; 201: 231-238.
32. Juhan CM, Alimi YS, Barthelemy PJ, Fabre DF, Riviere CS. Late results of iliofemoral venous thrombectomy. J Vasc Surg 1997; 25: 417-422.
33. Bank of Canada 10-year currency converter. Available at: http://www. bankofca nada. ca/rates/exchange/10-year-converter/. Accessed June 26, 2013.
34. Normand SLT, Landrum MB, Guadagnoli E, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: A matched analysis using propensity scores. J Clin Epidemiol 2001; 54: 387-398.
35. Christiansen SC, Cannegieter SC, Koster T, et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005; 293: 2352-2361.
36. Lefebvre P, Laliberté F, Nutescu EA, et al. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries. J Manag Care Pharm 2012; 18: 363-374.
37. Van Dongen CJ, Prandoni P, Frulla M, et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 2005; 3: 939-942.
38. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.
39. Bullano MF, Willey V, Wygant G, et al. Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During Hospitalization. J Manag Care Pharm 2005; 11: 663-673.